1. Friese J, Gleitz J, Gutser UT, Heubach JF, Matthiesen T, Wilffert B, Selve N. Aconitum sp. alkaloids: the modulation of voltage-dependent Na+ channels, toxicity and antinociceptive properties. Eur J Pharmacol. 1997. 337:165–174.
2. Kimura I, Makino M, Takamura Y, Islam MA, Kimura M. Positive chronotropic and inotropic effects of higenamine and its enhancing action on the aconitine-induced tachyarrhythmia in isolated murine atria. Jpn J Pharmacol. 1994. 66:75–80.
3. Catterall WA. Structure and function of voltage-sensitive ion channels. Science. 1988. 242:50–61.
4. Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol. 2000. 36:1–12.
5. Koller ML, Riccio ML, Gilmour RF Jr. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am J Physiol. 1998. 275:H1635–H1642.
6. Banville I, Chattipakorn N, Gray RA. Restitution dynamics during pacing and arrhythmias in isolated pig hearts. J Cardiovasc Electrophysiol. 2004. 15:455–463.
7. Wright SN. Comparison of aconitine-modified human heart (hH1) and rat skeletal (µ1) muscle Na+ channels: an important role for external Na+ ions. J Physiol. 2002. 538:759–771.
8. Chan TY. Aconite poisoning. Clin Toxicol. 2009. 47:279–285.
9. Arita J, Xue XY, Aye NN, Fukuyama K, Wakui Y, Niitsu K, Maruno M, Siying C, Hashimoto K. Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models. Eur J Pharmacol. 1996. 318:333–340.
10. Nattel S, Khairy P, Schram G. Arrhythmogenic ionic remodeling: adaptive responses with maladaptive consequences. Trends Cardiovasc Med. 2001. 11:295–301.
11. Li Y, Tu D, Xiao H, Du Y, Zou A, Liao Y, Dong S. Aconitine blocks HERG and Kv1.5 potassium channels. J Ethnopharmacol. 2010. 131:187–195.
12. Wang YJ, Chen BS, Lin MW, Lin AA, Peng H, Sung RJ, Wu SN. Time-dependent block of ultrarapid-delayed rectifier K+ currents by aconitine, a potent cardiotoxin, in heart-derived H9c2 myoblasts and in neonatal rat ventricular myocytes. Toxicol Sci. 2008. 106:454–463.
13. Cranefield PF. Action potentials, afterpotentials, and arrhythmias. Circ Res. 1977. 41:415–423.
14. Adaniya H, Hayami H, Hiraoka M, Sawanobori T. Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine. J Cardiovasc Pharmacol. 1994. 24:721–729.
15. Nolasco JB, Dahlen RW. A graphic method for the study of alternation in cardiac action potentials. J Appl Physiol. 1968. 25:191–196.
16. Elharrar V, Surawicz B. Cycle length effect on restitution of action potential duration in dog cardiac fibers. Am J Physiol. 1983. 244:H782–H792.
17. Garfinkel A, Chen PS, Walter DO, Karagueuzian HS, Kogan B, Evans SJ, Karpoukhin M, Hwang C, Uchida T, Gotoh M, Nwasokwa O, Sager P, Weiss JN. Quasiperiodicity and chaos in cardiac fibrillation. J Clin Invest. 1997. 99:305–314.
18. Qu Z, Garfinkel A, Chen PS, Weiss JN. Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue. Circulation. 2000. 102:1664–1670.
19. Wilson LD, Rosenbaum DS. Mechanisms of arrhythmogenic cardiac alternans. Europace. 2007. 9:vi77–vi82.